Safety Study of F2695 SR in Major Depressive Disorder

NCT ID: NCT01034267

Last Updated: 2012-08-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

828 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Major Depressive Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Depression Major Depressive Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

(Open-label) F2695 SR capsules, oral administration, once daily, flexible dosing

Group Type EXPERIMENTAL

F2695 SR

Intervention Type DRUG

Drug F2695 SR (flexible dose) to be given orally in capsule form once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

F2695 SR

Drug F2695 SR (flexible dose) to be given orally in capsule form once daily

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Completed 1 of the lead-in studies LVM-MD-01, LVM-MD-02, or LVM-MD-03
* Have normal examination findings at the final visit of the lead-in study
* Have a negative serum pregnancy test at the final visit of the lead-in study if a woman of child-bearing potential

Exclusion Criteria

* Any exclusionary psychiatric or medical condition that developed during the lead in study
* Patients considered a suicide risk
* Women who are pregnant, breastfeeding, or planning to become during the study OR are sexually active and not currently using a medically acceptable method of contraception
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Forest Laboratories

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Giovana Forrero, MA

Role: STUDY_DIRECTOR

Forest Research Institute, a subsidiary of Forest Laboratories Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Forest Investigative Site 55

Dothan, Alabama, United States

Site Status

Forest Investigative Site 29

Scottsdale, Arizona, United States

Site Status

Forest Investigative Site 31

Beverly Hills, California, United States

Site Status

Forest Investigative Site 3

Costa Mesa, California, United States

Site Status

Forest Investigative Site 12

Encino, California, United States

Site Status

Forest Investigative Site 6

Escondido, California, United States

Site Status

Forest Investigative Site 22

Oceanside, California, United States

Site Status

Forest Investigative Site 38

Sherman Oaks, California, United States

Site Status

Forest Investigative Site 36

Denver, Colorado, United States

Site Status

Forest Investigative Site 28

Denver, Colorado, United States

Site Status

Forest Investigative Site 65

Highlands Ranch, Colorado, United States

Site Status

Forest Investigative Site 30

Cromwell, Connecticut, United States

Site Status

Forest Investigative Site 57

Boca Raton, Florida, United States

Site Status

Forest Investigative Site 60

Boca Raton, Florida, United States

Site Status

Forest Investigative Site 18

Coral Springs, Florida, United States

Site Status

Forest Investigative Site 34

Fort Myers, Florida, United States

Site Status

Forest Investigative Site 64

Gainesville, Florida, United States

Site Status

Forest Investigative Site 45

Hallandale, Florida, United States

Site Status

Forest Investigative Site 17

Jacksonville, Florida, United States

Site Status

Forest Investigative Site 53

Ocala, Florida, United States

Site Status

Forest Investigative Site 13

Orlando, Florida, United States

Site Status

Forest Investigative Site 61

Orlando, Florida, United States

Site Status

Forest Investigative Site 27

West Palm Beach, Florida, United States

Site Status

Forest Investigative Site 59

Winter Park, Florida, United States

Site Status

Forest Investigative Site 70

Atlanta, Georgia, United States

Site Status

Forest Investigative Site 66

Smyrna, Georgia, United States

Site Status

Forest Investigative Site 33

Chicago, Illinois, United States

Site Status

Forest Investigative Site 23

Hoffman Estates, Illinois, United States

Site Status

Forest Investigative Site 50

Oak Brook, Illinois, United States

Site Status

Forest Investigative Site 63

Indianapolis, Indiana, United States

Site Status

Forest Investigative Site 71

Prairie Village, Kansas, United States

Site Status

Forest Investigative Site 5

Wichita, Kansas, United States

Site Status

Forest Investigative Site 52

Shreveport, Louisiana, United States

Site Status

Forest Investigative Site 1

Baltimore, Maryland, United States

Site Status

Forest Investigative Site 2

Glen Burnie, Maryland, United States

Site Status

Forest Investigative Site 37

Rockville, Maryland, United States

Site Status

Forest Investigative Site 32

Fall River, Massachusetts, United States

Site Status

Forest Investigative Site 15

East Lansing, Michigan, United States

Site Status

Forest Investigative Site 35

Cherry Hill, New Jersey, United States

Site Status

Forest Investigative Site 21

Willingboro, New Jersey, United States

Site Status

Forest Investigative Site 51

Brooklyn, New York, United States

Site Status

Forest Investigative Site 42

Brooklyn, New York, United States

Site Status

Forest Investigative Site 4

Mount Kisco, New York, United States

Site Status

Forest Investigative Site 16

New York, New York, United States

Site Status

Forest Investigative Site 39

New York, New York, United States

Site Status

Forest Investigative Site 9

Staten Island, New York, United States

Site Status

Forest Investigative Site 46

Raleigh, North Carolina, United States

Site Status

Forest Investigative Site 25

Canton, Ohio, United States

Site Status

Forest Investigative Site 10

Dayton, Ohio, United States

Site Status

Forest Investigative Site 56

Oklahoma City, Oklahoma, United States

Site Status

Forest Investigative Site 67

Oklahoma City, Oklahoma, United States

Site Status

Forest Investigative Site 40

Portland, Oregon, United States

Site Status

Forest Investigative Site 58

Salem, Oregon, United States

Site Status

Forest Investigative Site 54

Allentown, Pennsylvania, United States

Site Status

Forest Investigative Site 14

Media, Pennsylvania, United States

Site Status

Forest Investigative Site 43

Norristown, Pennsylvania, United States

Site Status

Forest Investigative Site 24

Philadelphia, Pennsylvania, United States

Site Status

Forest Investigative Site 44

Lincoln, Rhode Island, United States

Site Status

Forest Investigative Site 26

Memphis, Tennessee, United States

Site Status

Forest Investigative Site 20

Dallas, Texas, United States

Site Status

Forest Investigative Site 47

Dallas, Texas, United States

Site Status

Forest Investigative Site 62

San Antonio, Texas, United States

Site Status

Forest Investigative Site 7

San Antonio, Texas, United States

Site Status

Forest Investigative Site 8

Woodstock, Vermont, United States

Site Status

Forest Investigative Site 68

Virginia Beach, Virginia, United States

Site Status

Forest Investigative Site 19

Bellevue, Washington, United States

Site Status

Forest Investigative Site 41

Seattle, Washington, United States

Site Status

Forest Investigative Site 69

Spokane, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LVM-MD-04

Identifier Type: -

Identifier Source: org_study_id